ArticleDiscover oncology2025

Butyrate confers colorectal cancer cell resistance to anti-PD-1 therapy by promoting CPT1A-mediated fatty acid oxidation.

Ran Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.